Splenic Autotransplantation and the Immune System Adequate Testing Required for Evaluation of Effect
- 1 March 1992
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 215 (3) , 256-265
- https://doi.org/10.1097/00000658-199203000-00010
Abstract
The risk of severe infections after splenectomy, even after many years, is now well established. In attempts to prevent these infections, spleen-saving techniques, including autotransplantation of spleen fragments, have been performed, when possible in combination with vaccination. The problem in autotransplantation is the evaluation of functional activity. The results of the tests used until now often do not seem to correlate very well with the risk of developing an overwhelming postsplenectomy infection (OPSI). This may be related to the fact that the tests used evaluate general functions, and not specific spleen-related functions, such as the capacity to mount a primary response to certain polysaccharide antigens present in the capsule of bacteria known to cause OPSI. In this review, the significance of the spleen in the human immune system is discussed and the effects of splenectomy are described, including the precautions that can be taken to diminish the risk of postsplenectomy infections and sepsis. It appears that postsplenectomy vaccination is more successful when recently developed protein-conjugated polysaccharide vaccines are used. Because the present testing of the function of spleen autotransplants is not adequate, we suggest that new tests should be developed, employing appropriate polysaccharide antigens.Keywords
This publication has 47 references indexed in Scilit:
- Human marginal zone b cells are not an activated b cell subset: strong expression of cd21 as a putative mediator for rapid b cell activationEuropean Journal of Immunology, 1989
- The spleen in lymphocyte migrationImmunology Today, 1988
- Response to Oligosaccharide-Protein Conjugate Vaccine againstHemophilus influenzaeb in Two Patients with IgG2Deficiency Unresponsive to Capsular Polysaccharide VaccineNew England Journal of Medicine, 1986
- Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant.The Journal of Immunology, 1986
- Kinetic analysis of the blood clearance and organ uptake curves of IgG-coated red cells in HLA-typed controls and patients with Wegener's granulomatosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 1986
- Influence of carriers on the development and localization of anti‐2,4,6‐trinitrophenyl (TNP) antibody‐forming cells in the murine spleen: II. Suppressed antibody response to TNP‐Ficoll after elimination of marginal zone cellsEuropean Journal of Immunology, 1986
- Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type bThe Journal of Pediatrics, 1985
- IMPAIRED HUMAN ANTIBODY RESPONSE TO THE THYMUS-INDEPENDENT ANTIGEN, DNP-FICOLL, AFTER SPLENECTOMYThe Lancet, 1985
- Host Defense Against Streptococcus pneumoniae: The Role of the SpleenClinical Infectious Diseases, 1981
- IMMUNE RESPONSE AFTER SPLENECTOMYThe Lancet, 1978